Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 6

    1.
    2.

    MCF-7 cell apoptosis and cell cycle arrest: non-genomic effects of progesterone and mifepristone (RU-486).

    Fjelldal R, Moe BT, Ørbo A, Sager G.

    Anticancer Res. 2010 Dec;30(12):4835-40.

    PMID:
    21187460
    [PubMed - indexed for MEDLINE]
    3.

    Determination of glycodelin-A expression correlated to grading and staging in ovarian carcinoma tissue.

    Tsviliana A, Mayr D, Kuhn C, Kunze S, Mylonas I, Jeschke U, Friese K.

    Anticancer Res. 2010 May;30(5):1637-40.

    PMID:
    20592354
    [PubMed - indexed for MEDLINE]
    4.

    Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types.

    Check JH, Dix E, Cohen R, Check D, Wilson C.

    Anticancer Res. 2010 Feb;30(2):623-8.

    PMID:
    20332480
    [PubMed - indexed for MEDLINE]
    5.

    (-)-Gossypol containing hen sera and a myosin (-)-gossypol conjugate reduces the proliferation of MCF-7 cells.

    Reddish JM, Ye W, Lin YC, Wick M.

    Anticancer Res. 2010 Feb;30(2):439-44.

    PMID:
    20332451
    [PubMed - indexed for MEDLINE]
    6.

    Mifepristone treatment improves length and quality of survival of mice with spontaneous lung cancer.

    Check JH, Sansoucie L, Chern J, Dix E.

    Anticancer Res. 2010 Jan;30(1):119-22.

    PMID:
    20150625
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk